This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
CARD Trial
VISION Trial
mHSPC
ARASENS Trial
nmCRPC
ARAMIS Trial
PSMA PET Imaging
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
Advanced Bladder Cancer
JAVELIN Bladder 100 Trial
Centers of Excellence
Urologic Oncology
Left Group
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Petros Grivas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Kidney Cancer Today
Sumanta (Monty) Kumar Pal, MD
Jaime Landman, MD
Prostate Cancer
Advanced Prostate Cancer
Alicia Morgans, MD, MPH
CRPC with Bone Metastases
Rana R. McKay, MD
Imaging Center
Phillip Koo, MD
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
mHSPC
Alicia Morgans, MD, MPH
nmCRPC
Alicia Morgans, MD, MPH
PSMA-Targeted Therapy
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular, Penile, and Rare GU Malignancies
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Education
Covid-19
Urologic Oncology
Prostate Cancer
nmCRPC
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Pelvic Health & Reconstruction
Endourology
Testicular Cancer
Clinical Trials
From the Editor
Search Clinical Trials
Transformative Trials
DORA - PCCTC
IRONMAN - PCCTC
PROMISE - PCCTC
SPLASH Trial
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
AUA 2022
ASCO 2022
Upcoming
EAU 2022
See All
See All Conference Coverage
PCF
UroToday Home
Conference Highlights
Drug Development in Non-Muscle-Invasive Bladder Cancer (NMIBC) from Scientific, Regulatory, Clinician, and Patient Perspectives 2021 Annual Meeting
Viewing 1-15 of 15 articles
The Role of Radiology and Radiomics in Staging and Risk Stratification of Non-Muscle Invasive Bladder Cancer
Predicting Response to BCG
Special Considerations for Upper Tract Urothelial Carcinoma and Lynch Syndrome
Can We Identify Patients Who Should Undergo Immediate Cystectomy?
Novel and Multimodality Management Strategies for Localized Upper Tract Urothelial Carcinoma
Perioperative Chemotherapy and Targeted Therapy for Locally Advanced UTUC
Genomics of Upper Tract Urothelial Carcinoma
The Science of Combination Therapy in Non-Muscle-Invasive Bladder Cancer (NMIBC)
The Natural History of High-Risk NMIBC: Novel Therapies Versus Cystectomy
Sequential Therapy in BCG Unresponsive Disease
Keynote: Racial Disparities in Bladder Cancer Clinical Trials
Trial Design Considerations for Intermediate Risk Non Muscle-Invasive Bladder Cancer
What Novel Therapies Can Compete (or Combine) with BCG in BCG-naïve Non-Muscle Invasive Bladder Cancer (NMIBC)?
Model Systems to Facilitate Development of Therapies for Non-Muscle-Invasive Bladder Cancer
Regulatory Considerations in the BCG-Naïve Non-Muscle-Invasive Bladder Cancer Setting
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free
